NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.14
+0.17 (0.85%)
At close: Nov 13, 2026, 4:00 PM EST
20.53
+0.39 (1.94%)
After-hours: Nov 13, 2026, 7:30 PM EST

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $2.42 billion. The enterprise value is $1.77 billion.

Market Cap2.42B
Enterprise Value 1.77B

Important Dates

The last earnings date was Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

NAMS has 119.93 million shares outstanding. The number of shares has increased by 7.96% in one year.

Current Share Class 119.93M
Shares Outstanding 119.93M
Shares Change (YoY) +7.96%
Shares Change (QoQ) +0.62%
Owned by Insiders (%) 0.88%
Owned by Institutions (%) 75.29%
Float 81.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 93.13
Forward PS 62.39
PB Ratio 3.83
P/TBV Ratio 3.83
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 68.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.76, with a Debt / Equity ratio of 0.00.

Current Ratio 11.76
Quick Ratio 11.46
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -30.16% and return on invested capital (ROIC) is -21.47%.

Return on Equity (ROE) -30.16%
Return on Assets (ROA) -19.79%
Return on Invested Capital (ROIC) -21.47%
Return on Capital Employed (ROCE) -37.01%
Weighted Average Cost of Capital (WACC) 5.05%
Revenue Per Employee $259,370
Profits Per Employee -$2.05M
Employee Count100
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

In the past 12 months, NAMS has paid $1.21 million in taxes.

Income Tax 1.21M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.43% in the last 52 weeks. The beta is 0.15, so NAMS's price volatility has been lower than the market average.

Beta (5Y) 0.15
52-Week Price Change -47.43%
50-Day Moving Average 21.53
200-Day Moving Average 29.16
Relative Strength Index (RSI) 47.28
Average Volume (20 Days) 1,758,020

Short Selling Information

The latest short interest is 12.01 million, so 11.72% of the outstanding shares have been sold short.

Short Interest 12.01M
Short Previous Month 14.11M
Short % of Shares Out 11.72%
Short % of Float n/a
Short Ratio (days to cover) 8.31

Income Statement

In the last 12 months, NAMS had revenue of $25.94 million and -$204.89 million in losses. Loss per share was -$1.68.

Revenue25.94M
Gross Profit 25.94M
Operating Income -233.45M
Pretax Income -203.68M
Net Income -204.89M
EBITDA -233.20M
EBIT -233.45M
Loss Per Share -$1.68
Full Income Statement

Balance Sheet

The company has $643.13 million in cash and investments and $76,000 in debt, with a net cash position of $643.05 million or $5.36 per share.

Cash & Investments 643.13M
Total Debt 76,000
Net Cash 643.05M
Net Cash Per Share $5.36
Equity (Book Value) 630.78M
Book Value Per Share 5.26
Working Capital 615.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$150.47 million and capital expenditures -$395,000, giving a free cash flow of -$150.86 million.

Operating Cash Flow -150.47M
Capital Expenditures -395,000
Depreciation & Amortization 247,000
Net Borrowing n/a
Free Cash Flow -150.86M
FCF Per Share -$1.26
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -900.07%
Pretax Margin -785.29%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -7.96%
Shareholder Yield -7.96%
Earnings Yield -8.32%
FCF Yield -6.25%

Analyst Forecast

The average price target for NAMS is $50.12, which is 148.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $50.12
Price Target Difference 148.86%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (3Y) 131.40%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NAMS has an Altman Z-Score of 37.36 and a Piotroski F-Score of 1.

Altman Z-Score 37.36
Piotroski F-Score 1